Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OXERVATE - Health Canada Drug Approval Details

Approvals/Health Canada/OXERVATE

Authorized

STANDARD

OXERVATE

Dompe Farmaceutici SpA🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: a8f1d2cf1307dce0
Company: Dompe Farmaceutici SpA
Type: Standard

Approval Details

Approval Id: a8f1d2cf1307dce0
Drug Approval Canada Name: OXERVATE
Product Name: OXERVATE
Status: Cancelled Post Market
Status Date: 2024-07-17
Original Market Date: 2022-02-18
Din: 02485613
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: Schedule D , Prescription
Ahfs: 52:08.00
Atc Original: S01XA24 CENEGERMIN
Atc Name: s 01 xa 24
Aig Number: 0161210002
Company Name: Dompe Farmaceutici SpA
Company Address: Via Santa Lucia, 6, Milano, Milan, Italy, 20122
Company Detail Path: /organization/dompe-farmaceutici-spa

Company Information

Pharmaceutical Company Name: Dompe Farmaceutici SpA
Country Name: Italy
Website: http://www.dompe.it

Active Ingredients

CENEGERMIN

0.002 %

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a8f1d2cf1307dce0

Type

Standard

Back to Health Canada Approvals